44 related articles for article (PubMed ID: 22341207)
1. A record linkage process of a cervical cancer screening database.
Freire SM; de Almeida RT; Cabral MD; Bastos Ede A; Souza RC; da Silva MG
Comput Methods Programs Biomed; 2012 Oct; 108(1):90-101. PubMed ID: 22341207
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
3. Challenges of developing a cervical screening information system: the Ontario pilot project.
Marrett LD; Theis B; Baker MI; Whittick D
Cancer Prev Control; 1998 Oct; 2(5):221-7. PubMed ID: 10093636
[TBL] [Abstract][Full Text] [Related]
4. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
5. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
6. Screening for cervical cancer with the human papillomavirus test in an area of central Italy with no previous active cytological screening programme.
Confortini M; Giorgi Rossi P; Barbarino P; Passarelli AM; Orzella L; Tufi MC
J Med Screen; 2010; 17(2):79-86. PubMed ID: 20660436
[TBL] [Abstract][Full Text] [Related]
7. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
8. Cytological screening for cervical cancer in the province of Limburg, Belgium.
Arbyn M; Van Nieuwenhuyse A; Bogers J; De Jonge E; De Beeck LO; Matheï C; Buntinx F
Eur J Cancer Prev; 2011 Jan; 20(1):18-24. PubMed ID: 20805755
[TBL] [Abstract][Full Text] [Related]
9. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
10. The agreement between self-reported cervical smear abnormalities and screening programme records.
Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
[TBL] [Abstract][Full Text] [Related]
11. Screening history of women in Malmö with invasive cervical cancer.
Lindqvist PG; Hellsten C; Rippe A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
13. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening in the Czech Republic.
Tachezy R; Rob L
Coll Antropol; 2007 Apr; 31 Suppl 2():27-9. PubMed ID: 17598501
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
16. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
17. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.
Viikki M; Pukkala E; Hakama M
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):576-9. PubMed ID: 10929958
[TBL] [Abstract][Full Text] [Related]
18. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
[TBL] [Abstract][Full Text] [Related]
19. Cervical cytology during pregnancy--comparison with non-pregnant women and management of pregnant women with abnormal cytology.
Morimura Y; Fujimori K; Soeda S; Hashimoto T; Takano Y; Yamada H; Yanagida K; Sato A
Fukushima J Med Sci; 2002 Jun; 48(1):27-37. PubMed ID: 12365596
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.
Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
Eur J Cancer; 2011 Jul; 47(11):1633-46. PubMed ID: 21482103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
